Literature DB >> 3712970

Renal hemodynamics during separate and combined infusion of amino acids and dopamine.

P M ter Wee, J B Rosman, S van der Geest, W J Sluiter, A J Donker.   

Abstract

Healthy volunteers (N = 9) and patients with varying degrees of renal insufficiency (N = 36) were given a low dose of dopamine and/or amino acids intravenously during a simultaneous measurement of the glomerular filtration rate and the effective renal plasma flow. Dopamine infusion led to a rise in the glomerular filtration rate and a fall in the filtration fraction. Infusion of amino acids was accompanied by an increase in the glomerular filtration rate while the filtration fraction remained unchanged or increased slightly. The highest values for the glomerular filtration were obtained during the combined infusion of amino acids and dopamine. A reserve in filtration capacity was not or hardly present in patients with moderate (GFR 30 to 90 mliter/min/1.73 M2) to severe (GFR less than 30 mliter/min/1.73 M2) renal insufficiency. We conclude that dopamine decreases total renal vascular resistance while amino acids mainly reduce the tone of afferent arterioles. As amino acids and dopamine seem to be additive in their effects on the glomerular filtration rate, we recommend the combined infusion of these two stimuli to measure renal reserve filtration capacity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3712970     DOI: 10.1038/ki.1986.79

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  The effects of dopamine and a low protein diet on glomerular filtration rate and renal plasma flow in the aged kidney.

Authors:  G J Fancourt; V S Asokan; S C Bennett; J Walls; C M Castleden
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice.

Authors:  Gerd Luippold; Bärbel Pech; Swetlana Schneider; Karla Drescher; Reinhold Müller; Gerhard Gross; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-22       Impact factor: 3.000

3.  Postoperative medium-term follow-up of patients with bilateral, massive primary vesicorenal reflux and reduced renal function at presentation.

Authors:  G Belloli; G Bolla; F Cappellari; L Musi
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  [Behavior of the renal functional reserve in type I diabetic patients: effect of ACE-inhibition].

Authors:  T Eisenhauer; E Jungmann; D Warneboldt; G Ansorge; J Scherberich; J Talartschik
Journal:  Klin Wochenschr       Date:  1990-08-02

5.  Renal functional reserve in children with reduced renal mass: study by two dietary periods.

Authors:  C Antignac; C Kindermans; A M Dartois; M Dechaux; M Broyer; C Kleinknecht
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  [Loss of renal functional reserve following kidney transplantation and in patients with advanced disorders of liver function].

Authors:  T Eisenhauer; J Talartschik; H Hartmann; E Quentin; F Scheler
Journal:  Klin Wochenschr       Date:  1988-09-15

7.  The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure.

Authors:  T Robinson; S Gariballa; G Fancourt; J Potter; M Castleden
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

8.  Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazide.

Authors:  B Mühlbauer; E Hartenburg; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

9.  Impaired renal functional reserve and albuminuria in essential hypertension.

Authors:  A Losito; F Fortunati; I Zampi; A Del Favero
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

10.  Functional response of healthy and diseased glomeruli to a large, protein-rich meal.

Authors:  A Y Chan; M L Cheng; L C Keil; B D Myers
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.